site map
korean
english
  • 이미지

Home > About US > Menarini Group > Company Overview

Company Overview

  • Menarini Asia-Pacific improves the lives of people in the region by providing them rapid market access to innovative healthcare brands from around the world. We do this through our establ is hed global network, strong expertise across key therapeutic areas, proven brand and sales know -how, and deep experience in all major Asia-Pacific markets.


  • Menarini Asia-Pacific is a wholly owned subsidiary of the Menarini Group. Leveraging the strengt hs of its global infrastructure, we are able to tap onto extensive global resources and our own u nique local customer insights to deliver innovative brands from R&D, through to manufacturin g, regulatory approvals and commercialisation.


  • Through our team of over 3,300 passionate sales, marketing and support professionals, Menar ini Asia-Pacific manages a diverse portfolio of proprietary healthcare brands as well as licensed brands from global biotech and multinational companies.


  • Menarini Asia-Pacific operates in the fastest growing healthcare markets worldwide, increasing at an annual compounded growth rate of 12 percent, more than double the global growth rate for the sector. Today, the Asia-Pacific markets represent approximately USD104 billion and 12.3 percent of worldwide pharmaceutical sales.* With China and India among top growth contribut ors globally, Menarini Asia-Pacific is establishing itself as a leader in these rapidly expanding markets through targeted investments.
  • 블랙라인
  • Aside Information
  • Menarini Group
  • History
  • Global Reach
  • Our Footprint
  • Vision & Values
  • Our Responsibility
  • 레드라인
  • Featured Article
  • 블랙라인
  • Featured Brands
    • dermatix
    • priligy
    • fulcare
    • nebilet
    • zofenopril
    • godn